Pier Paolo Pandolfi

Specialty: Molecular Oncology

Location: Unknown, Unknown, Global

Tier: TITAN

H-Index: 159

Years Active: 0

Hospital Affiliations

• Beth Israel Deaconess - Member

Key Publications

1. "METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer." - Mol Cancer (2023)
2. "Cancer metabolism: fatty acid oxidation in the limelight." - Nat Rev Cancer (2013)
3. "Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity." - Cell (2015)
4. "A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?" - Cell (2011)
5. "Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway." - Science (2019)

Knowledge Graph Relationships

Pier Paolo Pandolfi is a Molecular Oncology specialist affiliated with Beth Israel Deaconess. Authored 5 scholarly articles.